BCTX Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (17 mai 2024 @ 22:00):

Stats
Dagens volum	161 625
Gjennomsnittsvolum	77 820.00
Markedsverdi	22.21M
EPS	$0 ( 2024-03-20 )
Neste inntjeningsdato	( $-0.200 ) 2024-06-10
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.760
ATR14	$0.0150 (1.08%)

Insider Trading

Date	Person	Action	Amount	type
2022-12-28	Bondarenko Jamieson	Buy	28 000	Common Shares
2022-12-23	Williams William V.	Buy	2 530	Warrant
2022-12-20	Bondarenko Jamieson	Buy	22 000	Common Shares
2022-08-01	Bondarenko Jamieson	Sell	0	Common Shares
2021-03-29	Bondarenko Jamieson	Sell	150 000	Option (Right to Buy)

INSIDER POWER
-65.20
Last 25 transactions
Buy: 52 530 \| Sell: 1 209 572

Volum Korrelasjon

Lang: 0.04 (neutral)

Kort: -0.16 (neutral)

Signal:(50.275) Neutral

BriaCell Therapeutics Korrelasjon

10 Mest positive korrelasjoner
FWRD	0.962
RDUS	0.956
PACB	0.955
KRNY	0.95
RICK	0.95
KLXE	0.95
PETS	0.949
GPRO	0.948
APPS	0.947
MKTW	0.947

10 Mest negative korrelasjoner
ACGL	-0.958
APXI	-0.949
DXJS	-0.945
ESTA	-0.944
BSCO	-0.94
IBKR	-0.937
INBKZ	-0.934
ARYD	-0.931
GHRS	-0.929
GOGL	-0.927

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

BriaCell Therapeutics Korrelasjon - Valuta/Råvare

-0.28
( neutral )

-0.41
( neutral )

0.00
( neutral )

0.47
( neutral )

-0.33
( neutral )

BriaCell Therapeutics Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$-15 529.00 (0.00 %)
EPS:	$-1.300

FY	2023
Omsetning:	$0
Bruttogevinst:	$-15 529.00 (0.00 %)
EPS:	$-1.300

FY	2022
Omsetning:	$0
Bruttogevinst:	$-15 141.00 (0.00 %)
EPS:	$-0.750

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-0.0900

Financial Reports:

No articles found.

BriaCell Therapeutics Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

BriaCell Therapeutics

BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.